Wuhan Haike Yingzhou Cultural Development Co., Ltd – Trademark Portfolio
Entity Type: 99
Wuhan Haike Yingzhou Cultural Development Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OCVERSE. The owner is based in Wuhan, Hubei.
505-506, Bldg Phase II,Creative Industry
Base, 465 Guanshan Ave., Donghu NTDZ
Wuhan, Hubei 430073 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wuhan Haike Yingzhou Cultural Development Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Wuhan Haike Yingzhou Cultural Development Co., Ltd have?
Wuhan Haike Yingzhou Cultural Development Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Wuhan Haike Yingzhou Cultural Development Co., Ltd file in?
Wuhan Haike Yingzhou Cultural Development Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Wuhan Haike Yingzhou Cultural Development Co., Ltd's most well-known trademarks?
Wuhan Haike Yingzhou Cultural Development Co., Ltd's registered trademark portfolio includes well-known marks such as OCVERSE. These are among 1 currently registered trademark in the portfolio.
What is Wuhan Haike Yingzhou Cultural Development Co., Ltd's trademark registration success rate?
Wuhan Haike Yingzhou Cultural Development Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.